Patents-Review.com
🔗 Permalink
Inventor profile of:

Philippe Letellier

City:

Orleans

Country:

France

Published Applications:

15

Last publication date:

2020-03-05

Top Assignees for applications by Philippe Letellier

The entities that hold a legal rights for patent applications filed by inventor Letellier Philippe:

Recent patent applications by Letellier Philippe

Philippe Letellier from Orleans, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-03-05
US20200069637A1
Human necessities

Salts of 3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl) phenoxy]ethyli-1-benzofuran-2-carboxamide, related crystalline forms, method for preparing the same and pharmaceutical compositions containing the same

 #2 | 2018-12-27
US20180369252A1
Human necessities

Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing it

 #3 | 2018-07-26
US20180207171A1
Human necessities

SALT OF 3-[(3-{[4-(4-MORPHOLINYLMETHYL)-1H-PYRROL-2-YL]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOL-5-YL)METHYL]-1,3-THIAZOLIDINE-2,4-DIONE, ITS PREPARATION, AND FORMULATIONS CONTAINING IT

 #4 | 2017-11-02
US20170313671A1
Chemistry; metallurgy

Salt or abexinostat, associated crystalline form, a process for their preparation and pharmaceutical compositions containing them

 #5 | 2017-09-21
US20170266151A1
Human necessities

Novel salts of 3-[(DIMETHYLAMINO)METHYL]-N--1-BENZOFURAN-2-CARBOXAMIDE, related crystalline forms, method for preparing the same and pharmaceutical compositions containing the same

 #6 | 2016-06-16
US20160168077A1
Chemistry; metallurgy

Forms of co-crystals of agomelatine and p toluenesulphonic acid, a process for their preparation and pharmaceutical compositions containing them

 #7 | 2016-06-09
US20160159735A1
Chemistry; metallurgy

Complexes of agomelatine and sulphonic acids, a process for their preparation and pharmaceutical compositions containing them

 #8 | 2016-06-02
US20160151378A1
Human necessities

Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing I

 #9 | 2015-11-05
US20150315167A1
Chemistry; metallurgy

NEW SALT OF ABEXINOSTAT, ASSOCIATED CRYSTALLINE FORM, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

 #10 | 2015-08-27
US20150238614A1
Human necessities

STABILISED AMORPHOUS FORM OF AGOMELATINE, A PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

 #11 | 2014-09-04
US20140249215A1
Chemistry; metallurgy

Salt of abexinostat, associated crystalline form, a process for their preparation and pharmaceutical compositions containing them

 #12 | 2014-06-05
US20140155453A1
Chemistry; metallurgy

SYNTHESIS PROCESS, AND CRYSTALLINE FORM OF 4-{3[CIS-HEXAHYDROCYCLOPENT A[CjPYRROL-2( 1 H)-YLjPROPOXYj BENZAMI DE HYDROCHLORI DE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

 #13 | 2014-04-10
US20140100374A1
Chemistry; metallurgy

Synthesis process, and crystalline form of 4-{3-[-hexahydrocyclopenta[]pyrrol-2(1)-yl]propoxy} benzamide hydrochloride and pharmaceutical compositions containing it

 #14 | 2012-12-13
US20120316245A1
Chemistry; metallurgy

Co-crystals of agomelatine, a process for there preparation and pharmaceutical compositions containing them

 #15 | 2012-12-13
US20120316214A1
Human necessities

Synthesis process, and crystalline form of 4-{3-[-hexahydrocyclopenta[]pyrrol-2(1)-yl]proxy}benzamide hydrochloride and pharmaceutical compositions containing it
InventorID:

720419 ⎘